Navigation Links
Linhardt to discuss drug safety and the impacts of globalization on pharmaceutical manufacturing
Date:2/1/2011

Troy, N.Y. Robert J. Linhardt will discuss drug safety in an increasingly global economy during the 2011 AAAS Annual Meeting in Washington, D.C.

Linhardt, the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of Biocatalysis and Metabolic Engineering at Rensselaer, will present on how to maintain a safe drug supply on Saturday, Feb. 19, from 8 to 9 a.m. in room 147B of the Washington Convention Center, during the symposium titled "Medicine Safety in a World of Science Without Borders."

Linhardt, who was named in 2009 as one the Scientific American 10 for his lifesaving work, is among the world's foremost experts on the commonly used blood thinner heparin. His research has helped make the currently available heparin safer for patients and is leading the effort to create a safer, fully synthetic alternative to the current heparin, which is harvested from the intestines of mostly foreign livestock. During the symposium, he will discuss this research and lessons that he learned when people around the world died after taking what were thought to be routine dosages of heparin.

Following the deaths of patients around the world from a dosage of heparin in early 2008, scientists scrambled to find the cause. In April 2008, Linhardt and a small team of scientists announced the source of the patient death and illness a complex carbohydrate named oversulfated chondroitin sulfate. It was a contaminant so structurally similar to heparin it was nearly undetectable to some of the most advanced technology available.

Linhardt and Jian Liu at the University of North Carolina discovered the "recipe" for synthetic heparin five years ago. Today, Linhardt and his team have prepared a purer, safer alternative creating the first fully synthetic heparin, and the largest amount ever created in the laboratory.

Linhardt will be joined in the discussion by fellow heparin experts Zachary Shriver of the Massachusetts Institute of Technology and Ali Al-Hakim of the U.S. Food and Drug Administration.


'/>"/>

Contact: Gabrielle DeMarco
demarg@rpi.edu
518-276-6542
Rensselaer Polytechnic Institute
Source:Eurekalert

Related medicine news :

1. mHealth Alliance Works in Partnership with GSMA to Expand Discussion of Mobile Health at 2010 Mobile World Congress
2. NAMI Encourages DSM-5 Discussion
3. WellPoint To Hold Conference Call and Webcast To Discuss 2010 Financial Outlook on March 17, 2010
4. The Future of Cosmetic Dermatology: Leading Dermatologist Dr. David Goldberg Discusses the Latest Facial Rejuvenation Techniques
5. David Anderson to discuss what model organisms can teach us about emotion
6. International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Networks Big Biz Show February 22, 2010 at 1:40 pm PST
7. NAE, IOM members to discuss engineering innovations in health care at Feb. 25 meeting
8. AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on Inside Government Radio Show
9. Six "Common Sense" Points Not Included In The Health Care Discussion? Should They Be?
10. Six "Common Sense" Points Not Included In The Health Care Discussion? Should They Be?
11. Improvements needed in genomic test result discussions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... 18, 2017 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that Mr. Michael Merges, Director of Strategic Growth, Catalent ... held at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, 2017. ...
(Date:1/18/2017)... ... January 18, 2017 , ... Floundering on New Year’s ... and the perfect time for a reset. The U.S. Apple Association agrees and recommends ... many of the factors that contribute to heart disease. , The U.S. Apple Association ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and ... or those who desire a more intimate review and analysis of its highlights, a ... to Bedside—is being offered by Imedex on February 4, 2017 in Chicago. Chaired by ...
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic ... National Association of Music Merchants (NAMM) winter trade show, Booth #2876, at the ... ER•4® has long been the gold standard for high-definition, in-ear earphones. This classic ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health is ... Health network on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, ... an exciting addition to our provider network, and the addition will benefit our ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, ... products to treat a variety of dermatological diseases, ... compound DMT210, in a Phase 2 acne rosacea ... to downregulate the proinflammatory cytokines in the skin ... acne rosacea. This clinical trial, ...
(Date:1/18/2017)... 18, 2017 The report " Automated Breast Ultrasound System ... Scanner), By End User (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, Regional Outlook ... Argentina , Germany , UK, France ... Russia , China , Japan , ... , Saudi Arabia , UAE, South Africa ...
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC today ... granted a Rare Pediatric Disease (RPD) designation for the ... Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. ... treatment is limited to supportive care. "The ... Drug Designation previously granted by the FDA in this ...
Breaking Medicine Technology: